RKDA 13G 1.03.23

Company

Arcadia Biosciences, Inc.

Filed

January 3, 2024

Accession Number

0001535610-24-000020

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →